Ustar Biotechnologies is a molecular diagnostic Company based in Hangzhou, China. The Company was founded in 2005 by scientists from the US with the goal of commercializing cutting-edge molecular technologies for the point-of-care. Ustar’s initial focus is on the development of diagnostics for low-resource areas, and its first product for TB screening was launched in the Chinese market in early 2014. This lead product involves Instrument-free amplification and detection of TB DNA. The Company is now making the transition from a small Chinese manufacturer to an international IVD development and manufacturing company.